GSK Says Most Cost Charges Will Fall in 2026 and 2027
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Empyrean Tech Q3 Net Profit Rises 1,101.50% Year Over Year
M impact | EQUITY | Oct 29, 2026, 09:58 AM UTC
Tinci Materials Says Q3 Net Profit Rose 581.69% Year Over Year
M impact | EQUITY | Oct 29, 2026, 09:58 AM UTC
Marvell Shares Slide 9.7% as Lumentum Rises 6.0% on Buyout Report
Marvell shares fell 9.7% in premarket trading, while Lumentum rose 6.0%, after a report of Marvell's interest in acquiring the optical-networking company.
M impact | EQUITY | Oct 29, 2026, 09:58 AM UTC
APAR Industries Q2 2027 Earnings Call Begins
APAR Industries’ quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 09:57 AM UTC
Takeda Pharmaceutical Company’s Q2 2027 earnings call begins
Takeda Pharmaceutical Company’s quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 09:57 AM UTC
Montage Tech Q3 Net Profit Rises 161.98% Year Over Year
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC